MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) shares shot up 19.5% during trading on Friday . The stock traded as high as $11.35 and last traded at $11.35. 1,900 shares were traded during trading, an increase of 225% from the average session volume of 585 shares. The stock had previously closed at $9.50.
MedTech Acquisition Stock Up 19.5%
The company has a fifty day moving average of $11.35 and a 200-day moving average of $11.35.
About MedTech Acquisition
MedTech Acquisition Corporation is a special purpose acquisition company formed in 2021 under the laws of Delaware and listed on the OTC Markets. The company’s primary objective is to complete a business combination with one or more businesses in the medical technology or life sciences sectors. By structuring as a blank check company, MedTech Acquisition seeks to leverage public market capital and strategic support to accelerate growth in a highly innovative industry.
MedTech Acquisition targets companies operating in areas such as diagnostic imaging, minimally invasive devices, regenerative medicine and digital health.
Read More
- Five stocks we like better than MedTech Acquisition
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
